Responses induced by tacrine in neuronal and non-neuronal cell lines

Journal of Neuroscience Research

Volumn 52, Issue 4, 1998, Pages 435-444

  De Ferrari, Giancarlo V ^a   Von Bernhardi, Rommy ^a,b   Calderón, Frances H ^a   Luza, Sandra C ^a   Inestrosa, Nibaldo C ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b UNIVERSIDAD DE LOS ANDES   (Chile)

Author keywords

Degeneration; Differentiation; Glia; MTT assay; Neurons; Tacrine

Indexed keywords

CHOLINESTERASE INHIBITOR; LACTATE DEHYDROGENASE; TACRINE;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL STRUCTURE; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY TEST; DRUG APPROVAL; DRUG EFFECT; FOOD AND DRUG ADMINISTRATION; NERVE CELL; NERVE CELL CULTURE; NONHUMAN; PRIORITY JOURNAL;

EID: 0032524158     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4547(19980515)52:4<435::AID-JNR7>3.0.CO;2-A     Document Type: Article

References (42)

1. Arendt T, Brückner MK, Lange M, Bigl V (1992): Changes in acetylcholinesterase and butyrylcholinesterase in Alzheimer's disease resemble embryonic development. A study of molecular forms. Neurochem Int 21:381-396.
2. Bagetta G, Corasaniti MT, Melino G, Paoletti AM, Finazzi-Agro A, Nistico G (1993): Lithium and tacrine increase the expression of nitric oxide synthase mRNA in the hippocampus of rat. Biochem Biophys Res Commun 197:1132-1139.
3. Berman HA, Leonard K (1992): Interaction of tetrahydroaminoacridine with acetylcholinesterase and butyrylcholinesterase. Mol Pharmacol 41:412-418.
4. Bronfman FC, Fernandez HL, Inestrosa, NC (1996): Amyloid precursor protein fragment and acetylcholinesterase increase with cell confluence and differentiation in a neuronal cell line Exp Cell Res 229:93-99.
5. Calderón FH, De Ferrari GV, Luza SC, von Bernhardi R, Inestrosa NC (1996): Toxic effects of acetylcholinesterase in neuronal cell cultures. Molec Biol Cell (Suppl.) 7: 652a, 3791.
6. Cummings JL, Khachaturian Z (1996): Definitions and diagnostic criteria. In Gauthier S (ed): "Clinical Diagnosis and Management of Alzheimer's Disease." London, UK: Martin Dunitz, Ltd., pp 3-15.
7. Davis KL, Powchik P (1995): Tacrine. Lancet 345:625-630.
8. Dolezal V, Tucek S (1991): Positive and negative effects of tacrine (tetrahydro-aminoacridine) and methoxytacrine on the metabolism of acetylcholine in brain cortical prisms incubated under "resting" conditions. J Neurochem 56:1207-1215.
9. Eichler J, Anselmet A, Sussman JL, Massoulie J, Silman I (1994): Differential effects of 'peripheral' site ligands on Torpedo and chicken acetylcholinesterase. Mol Pharmacol 45:335-340.
10. 4) acetylcholinesterase: Structure, localization, and physiological regulation. J. Neurochem 66:1335-1346.
11. Greenfield S (1996): Non-classical actions of cholinesterases: Role in cellular differentiation, tumorigenesis and Alzheimer's disease. Neurochem Int 28:485-490.
12. Hershkowitz N, Rogawski MA (1991): Tetrahydroaminoacridine block of N-methyl-D-aspartate-activated cation channels in cultured hippocampal neurons. Mol Pharmacol 39:592-598.
13. Inestrosa NC, Alvarez A, Perez C, Moreno RD, Vicente M, Linker C, Casanueva O, Soto C, Garrido J (1996): Acetylcholinesterase accelerates assembly of amyloid-β-peptides into Alzheimer's fibrils: Possible role of the peripheral site of the enzyme. Neuron 16:881-891.
14. Inestrosa NC, Alvarez A, Garrido J, Calderón FH, Bronfman FC, Dajas F, Gentry MK, Doctor BP (1997): Acetylcholinesterase promotes Alzheimer β-amyloid fibril formation. In Iqbal K, Winblad B, Nishimura T, Takeda M, Wisniewski HM (eds): "Alzheimer's Disease: Biology, Diagnosis and Therapeutics." London, UK: John Wiley & Sons, pp 499-508.
15. Jobin C, Gauthier J (1997): Differential effects of cell density on 5-lipoxygenase (5-LO), five-lipooxygenase-activating protein (FLAP) and interleukin-1 beta (IL-1 beta)expression in human neutrophils. Inflammation 21:235-250.
16. Kalaria RN, Kroon SN, Grahovac I, Perry G (1992): Acetylcholinesterase and its association with heparan sulphate proteoglycans in cortical amyloid deposits of Alzheimer's disease. Neuroscience 51:177-184.
17. Kasa P, Rakonczay Z, Gulya K (1997): The cholinergic system in Alzheimer's disease. Prog Neurobiol 52:511-535.
18. Lahiri DK (1994): Reversibility of the effect of tacrine on the secretion of the beta-amyloid precursor protein in cultured cells. Neurosci Lett 181:149-152.
19. Lahiri DK, Lewis S, Farlow MR (1994): Tacrine alters the secretion of the beta-amyloid precursor protein in cell lines. J Neurosci Res 37:777-787.
20. Mesulam M-M (1986): Alzheimer plaques and cortical cholinergic innervation. Neuroscience 17:275-276.
21. Mesulam M-M, Geula C, Morán MA (1987): Anatomy of cholinesterase inhibition in Alzheimer's disease: Effect of physostigmine and tetrahydroaminoacridine on plaques and tangles. Ann Neurol 22: 683-691.
22. Morán MA, Mufson EJ, Gómez-Ramos P (1993): Colocalization of cholinesterases with β amyloid protein in aged and Alzheimer's brain. Acta Neuropathol. 85: 362-369.
23. Morris JC (1995): Relationship of plaques and tangles to Alzheimer's disease phenotype. In Goate A, Ashall F (eds): "Pathobiology of Alzheimer's Disease." London, New York: Academic Press Limited, pp 193-223.
24. Mosmann T (1983): Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxic assays. J Immunol Methods 65:55-63.
25. Nilsson-Hakansson L, Lai Z, Nordberg A (1990): Tetrahydroaminoacridine induces opposite changes in muscarinic and nicotinic receptors in rat brain. Eur J Pharmacol 186:301-305.
26. Pang YP, Quiram P, Jelacic T, Hong F, Brimijoin S (1996). Highly potent, selective, and low cost bis-tetrahydroaminacrine inhibitors of acetylcholinesterase. Steps toward novel drugs for treating Alzheimer's disease. J Biol Chem 271:23646-23649.
27. Perry EK, Tomlinson BE, Blessed G, Bergmann K, Gibson PH, Perry RH (1978): Correlation of cholinergic abnormalities with senile plaques and mental scores in dementia. Br Med J: 1457-1459.
28. Perry EK, Smith CJ, Court JA, Bonham JR, Rodway M, Atack JR (1988): Interaction of 9-amino-1,2,3,4-tetrahydroamino-acridine (THA) with human cortical nicotinic and muscarinic receptor binding in vitro, Neurosci Lett 91:211-216.
29. Prasad KN (1975): Differentiation of neuroblastoma cells in culture. Biol Rev 50:129-265.
30. Schneider LS, Forette F (1996): AD symptomatic drugs: Tacrine. In Gauthier S (ed): "Clinical Diagnosis and Management of Alzheimer's Disease." London, U.K.: Martin Dunitz, Ltd., pp 221-237.
31. Schorderet M (1995): Alzheimer's disease: Fundamental and therapeutic aspects. Experientia 51:99-105.
32. Schubert D, Heinemann S, Carlisle W, Tarikas H, Kimes B, Steinbach JH, Culp W, Brandt BL (1974): Clonal cell lines from the rat central nervous system. Nature 249:224-227.
33. Selkoe DJ (1996): Amyloid β-protein and the genetics of Alzheimer's disease. J Biol Chem 271:18295-18298.
34. Shaddock JG, Feuers RJ, Chou MW, Swenson DH, Casciano DA (1995): Genotoxicity of tacrine in primary hepatocytes isolated from B6C3F1 mice and aged ad libitum and calorie restricted Fischer 344 rats. Mutat Res 344:79-88.
35. Shen Z-X (1994): Acetylcholinesterase provides deeper insights into Alzheimer's disease. Med Hypoth 43:21-30.
36. Small DH, Michaelson S, Sberna G (1996): Non-classical actions of cholinesterases: Role in cellular differentiation, tumorigenesis and Alzheimer's disease. Neurochem Int 28:453-483.
37. Soto C, Brañes MC, Alvarez J, Inestrosa NC (1994): Structural determinants of the Alzheimer's amyloid β-peptide. J Neurochem 63: 1191-1198.
38. Tucek S, Dolezal V (1991): Negative effects of tacrine (tetrahydroaminoacridine) and methoxytacrine on the metabolism of acetylcholine in brain slices incubated under conditions stimulating neurotransmitter release. J Neurochem 56:1216-1221.
39. Vial JD, Garrido J (1976): Actin-like filaments and membrane rearrangement in oxyntic cells. Proc Natl Acad Sci USA 73: 4032-4036.
40. Watkins PB, Zimmerman HJ, Knapp MJ, Gracon SI, Lewis KW (1994): Hepatotoxic effects of tacrine administration in patients with Alzheimer's disease. JAMA 271:992-998.
41. Whitehouse PJ, Price DL, Struble RG, Coyle JT, DeLong MR (1982): Alzheimer's disease and senile dementia: Loss of neurons in the basal forebrain. Science 215:1237-1239.
42. Younkin SG, Goodridge B, Katz J, Lockett G, Nafziger D, Usiak MF, Younkin LH (1986): Molecular forms of acetylcholinesterase in Alzheimer's disease. Fedn Proc 45:2982-2988.